Clinical trial

Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)

NCT01650792

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Aspirin Normalized identity: aspirinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2012-07-01

PhasePHASE4

Conditions

Chagas Disease With Heart Failureunresolved

Interventions

AspirinDRUG · verified · RxNorm: aspirin

Sponsors & collaborators

Federal University of Bahialead sponsor

National Institutes of Health (NIH)collaborator

National Institute of Neurological Disorders and Stroke (NINDS)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01650792 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.